(Total Views: 83)
Posted On: 01/03/2024 10:25:46 AM
Post# of 47

$GLYC News Article - Apollomics Completes Enrollment in Phase 3 Bridging Study of Uproleselan in Chinese Patients with Relapsed/Refractory Acute Myeloid Leukemia https://marketwirenews.com/news-releases/apol...09454.html


My Twitter: WhyteStocks